The 12th Man has funded and fueled a top-10 program without the matching trophy case. Armed with real stability and star power, the Aggies are building to rewrite their narrative.
Vor Biopharma (VOR) has transformed into a late-stage autoimmune drug developer, focusing on telitacicept, a dual BAFF/APRIL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results